SCHEMBL1014502

SCHEMBL1014502

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(C2CCCCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 3/20 0.52
EPHX2 P34913 1/20 0.44
KCNJ6 P48051 1/20 0.42
KCNJ3 P48549 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
MAPT P10636 3/20 0.40
DRD4 P21917 2/20 0.40
DRD2 P14416 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
DRD3 P35462 1/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015307 0.90 SERPINE1 (0.64) SERPINE1EPHX2KCNJ6KCNJ3ALDH1A1
SCHEMBL1013722 0.89 SERPINE1 (0.52) SERPINE1KCNJ6KCNJ3ALDH1A1HPGD
SCHEMBL419440 0.86 SERPINE1 (0.52) SERPINE1KCNJ6KCNJ3ALDH1A1MAPT
SCHEMBL1015912 0.81 RAB9A (0.55) ALDH1A1HPGDKDM4ESMN1; SMN2MEN1
SCHEMBL1015672 0.81 ALDH1A1 (0.58) ALDH1A1HPGDMAPTKDM4EGAA
SCHEMBL1018800 0.81 GRIK1 (0.47) SERPINE1ALDH1A1HPGDMAPTKDM4E
SCHEMBL421027 0.80 SERPINE1 (0.78) SERPINE1ALDH1A1HPGDMAPTKDM4E
SCHEMBL1015276 0.79 SERPINE1 (0.65) SERPINE1KCNJ6KCNJ3ALDH1A1HPGD
SCHEMBL1797516 0.79 ALDH1A1 (0.50) ALDH1A1HPGDMAPTKDM4EGAA
SCHEMBL1015881 0.79 MITF (0.58) SERPINE1ALDH1A1HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885EPHX2 1533/4885KCNJ6 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.